Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Launched by AIN SHAMS UNIVERSITY · Aug 1, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment for male pattern hair loss, known as androgenetic alopecia. Researchers are testing whether injecting tiny particles called exosomes into the scalp can help improve hair growth. These exosomes are believed to support the health of hair follicles, and the study will look at both how the treatment works in the body and how it affects hair growth over time.

Men between the ages of about 18 and 65 with mild to moderate hair loss (grades 1 to 4) may be able to join the study. However, those with certain blood disorders, who are currently receiving other treatments for hair loss, have a history of cancer, or have had allergic reactions to similar treatments will not be eligible. Participants can expect to receive injections directly into the scalp and have their progress monitored carefully. It’s important to know that this study is still in the early phase and is not yet recruiting volunteers.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • - Androgenetic Alopecia Grades 1-4
• Exclusion Criteria:
• • blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes